Most patients I see take one or more vitamin or nutritional supplements. They take them for various reasons, but primarily in the hope that they will preserve health and prevent chronic disease — heart disease, cancer, high blood pressure, diabetes. More often than not, these supplements make a significant dent in their finances.

Are they worth the money? Do they deliver on any of these promises? Is there reason for concern?

An assortment of vitamin and dietary supplement pills
For prevention in healthy people, the evidence has not been kind to the bottle.

What I wrote the first time, and why I am revisiting it

I first wrote this article after the Archives of Internal Medicine published the Iowa Women’s Health Study analysis: 38,772 older women followed from 1986 to 2008, reporting their supplement use along the way.1 The supplements examined included vitamin B6, folic acid, iron, magnesium, zinc, copper and calcium.

The results were striking. Not only was there no mortality benefit — for most of the supplements studied there was an increase in mortality. Multivitamin use was associated with roughly a 2.4% absolute increase in risk of death over the follow-up period, and iron looked worse the more of it women took. Calcium was the sole exception, associated with lower mortality.

At the time, that was one large observational study, and I said so. Observational studies show associations, not causes; people who take supplements differ from people who don’t in a hundred ways researchers cannot fully measure. The honest position in 2015 was that the promise had not been demonstrated and the evidence was pointing the wrong way.

Since then, the large randomised trials have reported. Randomised trials settle the question observational studies can only raise, because the coin toss removes the confounding. We now have a much clearer answer, and it is close to the one the Iowa data hinted at.

What eleven more years of evidence showed

In 2022 the US Preventive Services Task Force — the body that grades preventive interventions for American medicine — completed its review of 84 studies including 52 published since its previous look.2,3 Its conclusions were plain:

The 2022 USPSTF verdict on supplements for preventing cancer and heart disease

  • Beta-carotene: recommended against. Not merely useless — harmful.
  • Vitamin E: recommended against. No benefit, and reason for concern.
  • Multivitamins: insufficient evidence to establish benefit or harm. The small signal for cancer incidence was not enough to recommend them.
  • Single and paired nutrients: insufficient evidence.

Applies to healthy adults taking supplements to prevent disease. It says nothing about treating a diagnosed deficiency, which is a different question entirely.

The individual trials tell the same story in more detail. VITAL randomised 25,871 American adults to 2,000 IU of vitamin D and to one gram of marine omega-3 daily, and followed them for a median of 5.3 years. Neither reduced the primary cancer or cardiovascular endpoints.4,5 The fracture arm found that vitamin D did not reduce fractures either — not total, not hip, not wrist — in adults who were not vitamin D deficient to begin with.6 Australia’s D-Health trial gave more than 21,000 older adults a monthly high dose for five years and found no reduction in all-cause mortality.7

And in 2024, the National Cancer Institute pooled three American cohorts — 390,124 generally healthy adults followed for up to 27 years — specifically designed to overcome the biases that plague this literature. Daily multivitamin use was associated with no mortality benefit whatsoever. If anything the hazard ratio sat fractionally above 1.0.8

I want to be fair to the other side, because there is one genuine exception worth knowing about. The COSMOS trial, which randomised more than 21,000 older adults, found that a daily multivitamin modestly improved memory and slowed cognitive ageing across three separate substudies.9,10 The effect was small — on the order of slowing cognitive ageing by a couple of years on a memory test — and it has not yet been replicated by an independent group. It is the most promising finding in favour of multivitamins in a generation, and it is still a long way from a reason to expect a longer or healthier life from the bottle.

Where supplements did not merely fail — they harmed

This is the part that surprises people most, so it deserves specifics. These are not theoretical risks; they are the reasons trials were stopped early.

  • Beta-carotene. Two large trials in smokers — ATBC in Finland and CARET in the United States — found more lung cancer and more deaths in the supplemented groups. CARET was halted 21 months early.11,12 An antioxidant that is protective in carrots was harmful in a capsule.
  • Vitamin E. The SELECT trial randomised 35,533 healthy men. Men taking 400 IU of vitamin E daily had a 17% higher rate of prostate cancer — 76 cases per 1,000 men versus 65 on placebo over seven years.13
  • Fish oil. A 2024 analysis of 415,737 UK Biobank participants found that in people without existing heart disease, regular fish oil use was associated with a 13% higher risk of atrial fibrillation and a 5% higher risk of stroke. In people who already had cardiovascular disease, the same supplement was associated with benefit.14 The same pill, opposite directions, depending on who swallows it.

A nutrient that is beneficial in food, at food doses, in the company of everything else the food contained, is not the same thing as that nutrient isolated, concentrated, and taken alone for years.

You do not actually know what is in the bottle

Under the Dietary Supplement Health and Education Act of 1994, supplements in the United States are regulated more like food than like medicine. A manufacturer does not have to prove a product works, or even that it is safe, before selling it. The FDA’s power is largely to act after harm is reported.

What that means in practice is measurable. When researchers bought 25 melatonin gummy products and assayed them, 22 were inaccurately labelled. Actual melatonin content ranged from 74% to 347% of what the label claimed. One product contained no melatonin at all — but did contain 31 mg of CBD.15 These are products routinely given to children.

The consequences reach the hospital. An analysis of national surveillance data estimated about 23,000 emergency department visits a year in the United States attributable to supplement adverse events, most commonly cardiac symptoms in young adults taking weight-loss and energy products.16 And a 2024 analysis estimated that roughly 15 million American adults take at least one of six botanicals with documented reports of liver injury — turmeric, green tea extract, ashwagandha, garcinia cambogia, red yeast rice and black cohosh.17

I should be even-handed here: on a per-user basis those liver injuries are rare, and industry critics of that paper made the point fairly. But “rare” is a difficult trade when the expected benefit is zero. A small risk in exchange for a real benefit is medicine. A small risk in exchange for nothing is just a small risk.

The harm I actually see in clinic

Everything above concerns direct harm, and direct harm is the smaller problem. I do not think most supplements are killing anybody. What I think happens is subtler and far more common.

By investing their hopes for prevention — for more years, and better ones — in a daily handful of capsules, many people quietly stop placing the necessary emphasis on what actually works: how they eat, how they move, how they sleep. The supplement becomes a substitute for the thing it was meant to supplement.

Occasionally I meet patients who would rather spend their money on supplements than on good food. I find that genuinely troubling, particularly when I cannot restore their confidence that a decent diet is sufficient. It is the predictable result of aggressive marketing meeting an absence of meaningful regulation.

Let us be honest about why. It is far easier to swallow a few capsules each morning than to plan, shop, cook and sit down to a good meal. You do not break a sweat opening a bottle of nutraceuticals, the way you do walking for forty-five minutes.

When a supplement is exactly the right answer

None of this makes me anti-supplement. It makes me anti-guessing. There is a real and well-defined list of situations in which supplementation is correct, evidence-based medicine, and I prescribe from it regularly:

  • Folic acid in pregnancy. 400 to 800 µg daily for anyone who could become pregnant, started before conception. This prevents neural tube defects and is one of the best-supported preventive measures in all of medicine.18
  • Vitamin B12 for vegans and strict vegetarians, for people on long-term metformin or acid-suppressing medication, and for many adults over 60 whose absorption declines.
  • Vitamin D for people who are genuinely deficient, and at the recommended daily allowance for children, pregnant women, adults over 75, and adults with high-risk prediabetes. Note what the 2024 Endocrine Society guideline also says: healthy adults under 75 are unlikely to benefit from more than the RDA, and do not need their vitamin D level tested at all.19
  • Iron for documented iron deficiency — and only then. Iron is the supplement that looked worst in the Iowa data, and taking it without a deficiency is not a neutral act.
  • The AREDS2 formulation for people with established intermediate or advanced age-related macular degeneration, where it slows progression.20
  • Calcium and vitamin D where dietary calcium genuinely falls short, particularly after bariatric surgery or with osteoporosis under treatment.
  • Anything your own physician has prescribed for a diagnosed condition.

Notice the pattern. Every item on that list treats a specific, identified shortfall or condition. Not one of them is a healthy person taking something in the general hope of preventing something.

The question to ask before you buy anything

Here is what strikes me about the way supplements are actually bought. Almost nobody establishes that they are short of a nutrient before buying it. The sequence runs backwards: an advertisement, or a friend, or an article, suggests magnesium — and the bottle arrives before anyone has asked whether this particular person, eating this particular diet, is short of magnesium at all.

That question is answerable, and it does not require a blood test. Most of what you need to know is in what you already ate. Roughly half of Americans take in less magnesium than the estimated average requirement; nearly all fall short of the potassium recommendation from food alone.21 You may well be one of them — or you may not be, and the honest way to find out is to look.

This is precisely why I built VitalFill. Not to sell anyone a supplement, but to answer the question that should come first: am I actually short of anything? You log what you eat; it tracks calories and more than forty nutrients against targets set for your own age, sex, and whether you are pregnant or breastfeeding — and it shows you which ones are filled and which fall short.

If you have been short of vitamin B12 for a year, that is worth knowing and worth acting on. If your diet has been covering everything comfortably, that is worth knowing too, and it will save you a good deal of money.

VitalFill app icon

Find out what you are actually short of

Log food by voice, camera, or barcode. VitalFill tracks 40+ nutrients against targets personalised to you — so you supplement what you are missing, and stop paying for what you are not.

Coming to theApp Store Coming toGoogle Play

VitalFill is still in development. If you would like to know when it is ready, leave your name below and I will tell you — nothing else. I will never sell or share your email, and I use it only to write to you occasionally about this and similar tools I develop here.

In the meantime, you can try the nutrient tracker on this site, which runs the same calculations in your browser for a single day.

Conclusion

If little labour, little are our gains:
Man’s fortunes are according to his pains.
— Robert Herrick, Hesperides 752

Absorbing a bit too much of some nutrients, like the B vitamins, just results in “expensive urine”, because the excess is excreted.
— Kathi Kemper, MD, paediatrician

Eleven years and several hundred thousand randomised participants later, I would put it the same way I did then, with one addition.

If you want to reap the benefits of a healthy, fulfilling life, you have to be willing to do what it takes. There are no shortcuts. Not even supplements.

But if you are going to take something, take it for a reason you can name — a deficiency you have actually demonstrated, or a condition your doctor is actually treating. That is the difference between medicine and hope in a bottle.

Dr. Gily Ionescu, MS MD

What the terms in this article mean

Research on nutrition is written in a shorthand that is rarely explained to the people it is written for. Here it is in plain language.

Randomised controlled trial (RCT)
Participants are assigned to the supplement or a placebo by the equivalent of a coin toss. Because the toss is blind to everything about the person, the two groups end up alike in every respect except the pill — so a difference in outcome can reasonably be blamed on the pill. This is the only design that can demonstrate cause.
Observational study
Researchers watch what people already do and record what happens. Much cheaper and much longer-running than a trial, but people who choose to take supplements differ from people who don’t in ways that are impossible to fully account for. Observational studies raise questions well; they answer them poorly. The Iowa Women’s Health Study was observational. VITAL and SELECT were randomised trials.
Primary prevention
Trying to stop a disease from ever occurring in someone who does not have it. Distinct from treating a condition someone already has. Almost every disappointing supplement finding in this article concerns primary prevention.
Absolute vs. relative risk
A “17% increase” is relative — it describes the change compared with the starting risk, not the size of the risk itself. In SELECT, that 17% meant 76 prostate cancers per 1,000 men instead of 65: an absolute difference of 11 per 1,000. Both figures are true; the relative one always sounds larger.
Hazard ratio (HR)
How much faster an event happens in one group than the other over time. An HR of 1.00 means no difference; above 1.00 means more events in the treated group; below means fewer. In the 2024 multivitamin study the HR for death was 1.04 — no benefit, and a whisker on the wrong side.
RDA — Recommended Dietary Allowance
The daily intake expected to meet the needs of about 97% of healthy people of a given age and sex. It is deliberately set high enough to cover nearly everyone, so it is a comfortable target rather than a minimum you must hit daily.
EAR — Estimated Average Requirement
The intake that would meet the needs of half the population. Because it sits below the RDA, it is what researchers use to estimate how many people are genuinely falling short, rather than merely below an ambitious target.
DSHEA
The Dietary Supplement Health and Education Act of 1994, the American law that placed supplements under food rules rather than drug rules. It is the reason a supplement does not need to prove it works, or that it is safe, before it goes on sale.

References

Every claim above traces to one of these. Where a study is described in the text, the reference note says exactly what it was used for.

  1. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study. Arch Intern Med. 2011;171(18):1625–1633. doi:10.1001/archinternmed.2011.445 The original study this article was built around: 38,772 older women, no mortality benefit, and an association with higher mortality for most supplements studied.
  2. US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(23):2326–2333. doi:10.1001/jama.2022.8970 Source of the four verdicts in the callout box, including the recommendations against beta-carotene and vitamin E.
  3. O’Connor EA, Evans CV, Ivlev I, et al. Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022;327(23):2334–2347. doi:10.1001/jama.2021.15650 The underlying evidence review — 84 studies, 52 of them new since the previous assessment.
  4. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi:10.1056/NEJMoa1809944 The VITAL vitamin D arm: 25,871 participants, no reduction in cancer or cardiovascular events.
  5. Manson JE, Cook NR, Lee IM, et al. Marine n−3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380(1):23–32. doi:10.1056/NEJMoa1811403 The VITAL omega-3 arm, with the same null result for the primary endpoints.
  6. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299–309. doi:10.1056/NEJMoa2202106 The fracture finding: no reduction in total, hip or wrist fractures in adults not selected for deficiency.
  7. Neale RE, Baxter C, Romero BD, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120–128. doi:10.1016/S2213-8587(21)00345-4 Monthly high-dose vitamin D in over 21,000 older Australians, with no reduction in all-cause mortality.
  8. Loftfield E, O’Connell CP, Abnet CC, et al. Multivitamin use and mortality risk in 3 prospective US cohorts. JAMA Netw Open. 2024;7(6):e2418729. doi:10.1001/jamanetworkopen.2024.18729 390,124 healthy adults followed up to 27 years: no mortality benefit from daily multivitamins; hazard ratio 1.04.
  9. Baker LD, Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial. Alzheimers Dement. 2023;19(4):1308–1319. doi:10.1002/alz.12767 COSMOS-Mind: the first of the three cognition substudies showing a modest multivitamin benefit.
  10. Vyas CM, Manson JE, Sesso HD, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692–701. doi:10.1016/j.ajcnut.2023.12.011 The pooled COSMOS cognition analysis — the strongest evidence in favour of a multivitamin, and the reason I present it fairly rather than omitting it.
  11. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029–1035. doi:10.1056/NEJM199404143301501 The Finnish ATBC trial: more lung cancer in smokers given beta-carotene.
  12. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–1155. doi:10.1056/NEJM199605023341802 CARET, stopped early for harm — the trial referred to in the text.
  13. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549–1556. doi:10.1001/jama.2011.1437 Source of the 17% relative increase and the 76-versus-65 per 1,000 absolute figures.
  14. Chen G, Qian ZM, Zhang J, et al. Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study. BMJ Med. 2024;3(1):e000451. doi:10.1136/bmjmed-2022-000451 415,737 UK Biobank participants: higher atrial fibrillation and stroke risk in healthy users, benefit in those with existing cardiovascular disease.
  15. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA. 2023;329(16):1401–1402. doi:10.1001/jama.2023.2296 22 of 25 products inaccurately labelled; content 74% to 347% of label; one containing no melatonin but 31 mg of CBD.
  16. Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373(16):1531–1540. doi:10.1056/NEJMsa1504267 The estimate of roughly 23,000 supplement-related emergency department visits per year in the United States.
  17. Likhitsup A, Chen VL, Fontana RJ. Estimated exposure to 6 potentially hepatotoxic botanicals in US adults. JAMA Netw Open. 2024;7(8):e2425822. doi:10.1001/jamanetworkopen.2024.25822 The 15 million figure and the list of six botanicals. Industry critics have argued the per-user risk is low, and the article says so.
  18. US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023;330(5):454–459. doi:10.1001/jama.2023.12876 The 400–800 µg periconceptional recommendation — a grade A recommendation, and the clearest case for supplementation in the article.
  19. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907–1947. doi:10.1210/clinem/dgae290 Source of the current position: extra vitamin D for defined groups, the RDA for everyone else, and no routine testing in healthy adults under 75.
  20. The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005–2015. doi:10.1001/jama.2013.4997 The formulation referred to in the list of legitimate indications, for established macular degeneration.
  21. Reider CA, Chung RY, Devarshi PP, Grant RW, Hazels Mitmesser S. Inadequacy of immune health nutrients: intakes in US adults, the 2005–2016 NHANES. Nutrients. 2020;12(6):1735. doi:10.3390/nu12061735 Analysis of national dietary survey data behind the statement that large proportions of American adults fall below the estimated average requirement for several nutrients.

Originally published 8 May 2015. Substantially revised and updated 3 August 2026 to incorporate the randomised trial evidence published since.